<DOC>
	<DOCNO>NCT01318252</DOCNO>
	<brief_summary>The purpose study assess safety efficacy AL-54478 0.005 % compare Latanoprost 0.005 % AL-54478 Vehicle patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>AL-54478 Proof Concept Study</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Patients diagnose either OAG OHT . Patients able comply schedule visit . Patients physical exam within 6 month Screening Visit . Other protocoldefined inclusion criterion may apply . Females childbearing potential meet 1 follow condition : ) Currently pregnant ; b ) Positive urine pregnancy test ; c ) Intend become pregnant ; ) Breast feeding ; e ) Not use highly effective birth control measure . Patients extreme narrow angle complete partial closure . Patients cup disc ratio 0.8 . Patients severe central visual field loss either eye . Patients chronic recurrent inflammatory eye disease acute ocular infection inflammation . Patients ocular trauma within past 6 month intraocular surgery within past 6 month ocular laser surgery within past 3 month . Patients bestcorrect visual acuity less 20/80 . Patients ocular infection inflammation within past 3 month . Patients clinically relevant progressive retinal disease . Patients severe illness condition . Patients hypersensitivity prostaglandin analogu.e Patients unable safely discontinue IOPlowering medication washout . Patients currently therapy another investigational agent within 30 day prior Screening Visit . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Elevated IOP</keyword>
</DOC>